Company Active PRIVATE-LIMITED-GUARANT-NSC

Company profile

Bionow Limited

UK company 03898306, incorporated on 17 December 1999.

Bionow | Enabling the potential of business

Welcome to Bionow

Company number
03898306
Incorporated
17 Dec 1999
Companies House status
Active

Company identity

Founded / incorporated
17 December 1999

Company number 03898306

Verify at Companies House
Legal name
BIONOW LIMITED
Company type
PRI/LTD BY GUAR/NSC (Private, limited by guarantee, no share capital)
Region
Unknown
Registered address
REGUS 3RD FLOOR
82 KING STREET
MANCHESTER
UNITED KINGDOM
M2 4WQ
Insolvency history
No

Latest accounts

Financial period: 1 Apr 2024 to 31 Mar 2025

FILLETEDACCOUNTS
Turnover
Unknown
Profit / Loss
Unknown
Employees
7

Company events

Reference milestones and recent Companies House filing stream events.

5 events
29 May
2027

Confirmation statement due

Confirmation Due

Next confirmation statement due date

31 Dec
2026

Accounts due

Accounts Due

Next accounts due date

15 May
2026

Confirmation statement filed

Confirmation

Last confirmation statement made up date

31 Mar
2025

Accounts filed

Accounts

Last accounts made up date

17 Dec
1999

Incorporated

Inception

Company registered at Companies House

Public funding

2 awards
First funded
2023
Funded years
2023, 2024
Age at first award
23 years

Projects

2024 Collaborative R&D

UK Centre of Excellence in in-silico Regulatory Science and Innovation supporting the Entire Product Lifecycle in Life and Health Sciences – A network of enabling national capabilities

1 Mar 2024 to 31 Aug 2024

Awarded
£0
Total cost £0

A UK Centre of Excellence in in-silico Regulatory Science and Innovation (UK CEiRSI) will scale up activities of the InSilicoUK Pro-Innovation Regulations Network, in pioneering advanced computational modelling and simulation methods (CM&S), aka in-silico methods, to develop and regulate Life and Health Sciences products. Traditional testing for medical a...

2023 Collaborative R&D

Microbials Accelerator Programme

1 May 2023 to 31 Oct 2023

Awarded
£55,533
Total cost £55,533

no public description

Product types

Collaborative R&D